Aichi, Japan

Shiro Imagama

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Nagoya University, Seikagaku Corporation. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shiro Imagama. Retrieved from https://idiyas.com/inventor/shiro-imagama-7b7i5ks1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shiro Imagama: Innovator in Neuropathic Pain Treatment

Introduction

Shiro Imagama is a notable inventor based in Aichi, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of neuropathic pain. His innovative approach aims to provide alternatives to existing pain management therapies.

Latest Patents

Imagama holds a patent for an "Agent for Neuropathic Pain." The objective of this invention is to offer a substance that serves as an active ingredient for improving neuropathic pain. This agent operates through a mechanism of action that differs from currently available treatments. It is designed to minimize interactions with existing medications and reduce the risk of adverse reactions. The active ingredient in this agent is a lyase, specifically chondroitinase ABC, which degrades the chondroitin sulfate chain of proteoglycans.

Career Highlights

Throughout his career, Shiro Imagama has worked with prestigious institutions, including Nagoya University and Seikagaku Corporation. His research and development efforts have focused on creating effective solutions for neuropathic pain, showcasing his dedication to advancing medical science.

Collaborations

Imagama has collaborated with notable colleagues such as Yukihiro Matsuyama and Kenji Kadomatsu. These partnerships have contributed to the success of his research and the development of his innovative patent.

Conclusion

Shiro Imagama's work in developing an agent for neuropathic pain represents a significant advancement in pain management. His innovative approach and dedication to research continue to impact the medical field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…